• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

观察性研究:家庭医学住院医师中阿片类依赖孕妇的丁丙诺啡治疗:母婴结局报告。

Observational study of buprenorphine treatment of opioid-dependent pregnant women in a family medicine residency: reports on maternal and infant outcomes.

机构信息

the Maine Dartmouth Family Medicine Residency, Augusta, ME 04330.

出版信息

J Am Board Fam Med. 2011 Mar-Apr;24(2):194-201. doi: 10.3122/jabfm.2011.02.100155.

DOI:10.3122/jabfm.2011.02.100155
PMID:21383220
Abstract

PURPOSE

Within a family medicine residency, an outpatient buprenorphine treatment program was provided for pregnant women who were dependent on opioids. The purpose of this study was to investigate the outcomes of infants who were exposed to a range of doses of buprenorphine in utero and to determine how closely observed maternal/fetal outcomes (eg, method of delivery and infants requiring treatment for neonatal abstinence syndrome [NAS]) match those previously reported in the literature.

METHODS

This study consists of a retrospective case series of 23 infants born to 22 pregnant women who were dependent on opioids and who were treated with buprenorphine during a 31-month period.

RESULTS

Thirty-five percent of infants (8 of 23) required treatment for NAS. There was no significant relationship between maternal dose of buprenorphine and birth weight, NAS severity (ie, peak NAS score), or time to first peak NAS score. Infants born to tobacco users had a significantly lower birth weight (P = .0136) than infants born to nonusers. Seventy percent of infants (16 of 23) were breastfeeding at the time of discharge from the hospital.

CONCLUSIONS

The observations made in this case series are consistent with data previously reported in the literature. Infants in this study were more likely to be breastfed than those previously described by others, but further analysis is necessary to determine whether this finding is significant.

摘要

目的

在家庭医学住院医师培训中,为依赖阿片类药物的孕妇提供门诊丁丙诺啡治疗方案。本研究旨在调查胎儿暴露于丁丙诺啡不同剂量的婴儿的结局,并确定密切观察的母婴/胎儿结局(例如,分娩方式和需要治疗新生儿戒断综合征[NAS]的婴儿)与文献中先前报道的结局有多吻合。

方法

本研究包括 22 名依赖阿片类药物的孕妇所生的 23 名婴儿的回顾性病例系列研究,这些孕妇在 31 个月的时间里接受丁丙诺啡治疗。

结果

35%的婴儿(23 名中的 8 名)需要接受 NAS 治疗。母亲丁丙诺啡剂量与出生体重、NAS 严重程度(即,NAS 评分峰值)或首次 NAS 评分峰值的时间无显著关系。与非吸烟者相比,吸烟者所生婴儿的出生体重显著较低(P =.0136)。70%的婴儿(23 名中的 16 名)在出院时正在母乳喂养。

结论

本病例系列中的观察结果与文献中先前报道的数据一致。本研究中的婴儿更有可能进行母乳喂养,这比其他人之前描述的情况更为常见,但需要进一步分析以确定这一发现是否具有统计学意义。

相似文献

1
Observational study of buprenorphine treatment of opioid-dependent pregnant women in a family medicine residency: reports on maternal and infant outcomes.观察性研究:家庭医学住院医师中阿片类依赖孕妇的丁丙诺啡治疗:母婴结局报告。
J Am Board Fam Med. 2011 Mar-Apr;24(2):194-201. doi: 10.3122/jabfm.2011.02.100155.
2
Buprenorphine and methadone treatment of opiate dependence during pregnancy: comparison of fetal growth and neonatal outcomes in two consecutive case series.孕期阿片类药物依赖的丁丙诺啡和美沙酮治疗:两个连续病例系列中胎儿生长及新生儿结局的比较
Drug Alcohol Depend. 2008 Jul 1;96(1-2):69-78. doi: 10.1016/j.drugalcdep.2008.01.025. Epub 2008 Mar 19.
3
Breastfeeding rates and the relationship between breastfeeding and neonatal abstinence syndrome in women maintained on buprenorphine during pregnancy.孕期使用丁丙诺啡的女性母乳喂养率及母乳喂养与新生儿戒断综合征的关系。
J Midwifery Womens Health. 2013 Jul-Aug;58(4):383-8. doi: 10.1111/jmwh.12009.
4
Are there gender related differences in neonatal abstinence syndrome following exposure to buprenorphine during pregnancy?妊娠期间接触丁丙诺啡后,新生儿戒断综合征是否存在性别相关差异?
J Perinat Med. 2013 Sep 1;41(5):621-3. doi: 10.1515/jpm-2012-0288.
5
Prevention of Neonatal Abstinence Syndrome in an Outpatient Prenatal Buprenorphine Tapering Program.门诊美沙酮递减计划预防新生儿戒断综合征。
South Med J. 2020 Nov;113(11):553-558. doi: 10.14423/SMJ.0000000000001164.
6
Buprenorphine + naloxone in the treatment of opioid dependence during pregnancy-initial patient care and outcome data.丁丙诺啡/纳洛酮治疗妊娠期阿片类药物依赖:初步患者治疗和结局数据。
Am J Addict. 2013 May-Jun;22(3):252-4. doi: 10.1111/j.1521-0391.2012.12005.x.
7
Opioid maintenance treatment during pregnancy: occurrence and severity of neonatal abstinence syndrome. A national prospective study.孕期阿片类药物维持治疗:新生儿戒断综合征的发生和严重程度。一项全国性前瞻性研究。
Eur Addict Res. 2009;15(3):128-34. doi: 10.1159/000210042. Epub 2009 Mar 31.
8
Dual dilemma-should naltrexone be used in the treatment of opioid-dependent pregnant women?双重困境——纳曲酮是否应用于治疗阿片类药物依赖的孕妇?
Addiction. 2013 Feb;108(2):249-50. doi: 10.1111/j.1360-0443.2012.03883.x.
9
Buprenorphine versus methadone in the treatment of pregnant opioid-dependent patients: effects on the neonatal abstinence syndrome.丁丙诺啡与美沙酮治疗阿片类药物依赖孕妇:对新生儿戒断综合征的影响
Drug Alcohol Depend. 2005 Jul;79(1):1-10. doi: 10.1016/j.drugalcdep.2004.11.013.
10
Use of naltrexone in treating opioid use disorder in pregnancy.纳曲酮在治疗妊娠期阿片类药物使用障碍中的应用。
Am J Obstet Gynecol. 2020 Jan;222(1):83.e1-83.e8. doi: 10.1016/j.ajog.2019.07.037. Epub 2019 Jul 31.

引用本文的文献

1
Neonatal Abstinence Syndrome in Infants with Prenatal Exposure to Methadone versus Buprenorphine.产前暴露于美沙酮与丁丙诺啡的婴儿的新生儿戒断综合征
Children (Basel). 2023 Jun 8;10(6):1030. doi: 10.3390/children10061030.
2
Neonatal Outcomes after Combined Opioid and Nicotine Exposure in Utero: A Scoping Review.胎儿期同时暴露于阿片类药物和尼古丁后新生儿结局的研究:范围综述。
Int J Environ Res Public Health. 2021 Sep 28;18(19):10215. doi: 10.3390/ijerph181910215.
3
Buprenorphine dosing for the treatment of opioid use disorder through pregnancy and postpartum.
丁丙诺啡用于孕期及产后阿片类物质使用障碍治疗的剂量
Curr Treat Options Psychiatry. 2020 Sep;7(3):375-399. doi: 10.1007/s40501-020-00221-z. Epub 2020 Jul 28.
4
Outcomes of a novel office-based opioid treatment program in an internal medicine resident continuity practice.内科住院医师连续性实践中一种新型基于办公室的阿片类药物治疗方案的结果。
Addict Sci Clin Pract. 2019 Dec 19;14(1):46. doi: 10.1186/s13722-019-0175-z.
5
Examination of Hospital, Maternal, and Infant Characteristics Associated with Breastfeeding Initiation and Continuation Among Opioid-Exposed Mother-Infant Dyads.对阿片类药物暴露母婴二元组中与母乳喂养开始和持续相关的医院、母亲及婴儿特征的研究。
Breastfeed Med. 2018 May;13(4):266-274. doi: 10.1089/bfm.2017.0172. Epub 2018 Apr 9.
6
Maternal buprenorphine treatment and infant outcome.母亲丁丙诺啡治疗与婴儿结局。
Drug Alcohol Depend. 2017 Nov 1;180:56-61. doi: 10.1016/j.drugalcdep.2017.08.001. Epub 2017 Aug 31.
7
Pharmacological Management of Opioid Use Disorder in Pregnant Women.孕妇阿片类物质使用障碍的药物治疗
CNS Drugs. 2015 Aug;29(8):625-36. doi: 10.1007/s40263-015-0273-8.
8
Neonatal outcomes and their relationship to maternal buprenorphine dose during pregnancy.妊娠期间母亲丁丙诺啡剂量与新生儿结局及其关系。
Drug Alcohol Depend. 2014 Jan 1;134:414-417. doi: 10.1016/j.drugalcdep.2013.11.006. Epub 2013 Nov 16.
9
Buprenorphine use in pregnant opioid users: a critical review.孕期阿片类药物使用者中丁丙诺啡的使用:一项关键性综述。
CNS Drugs. 2013 Aug;27(8):653-62. doi: 10.1007/s40263-013-0072-z.
10
Buprenorphine treatment of opioid-dependent pregnant women: a comprehensive review.美沙酮治疗阿片类药物依赖孕妇:全面综述。
Addiction. 2012 Nov;107 Suppl 1(0 1):5-27. doi: 10.1111/j.1360-0443.2012.04035.x.